The invention relates to tetra-substituted heteroarylic compounds of the formula (I)
wherein X
1
, X
3
and X
4
are independently C or N, Y is C—H, N—H or N, wherein the total number of nitrogen atoms represented by X
1
, X
3
, X
4
and Y is 1 or 2; rings A and B are independently selected from phenyl or pyridyl; R1, R4, R′, R″, n and m are as defined herein. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of MDM2 and/or MDM4, or variants thereof.
本发明涉及公式(I)的四取代杂芳基化合物,其中X1、X3和X4独立地为C或N,Y为C-H、N-H或N,其中由X1、X3、X4和Y所代表的
氮原子的总数为1或2;环A和环B独立地选自
苯基或
吡啶基;R1、R4、R'、R"、n和m如本文所定义。这些化合物适用于治疗由M
DM2和/或M
DM4或其变异体的活性介导的疾病或疾患。